Supernus Pharmaceuticals Inc (SUPN): Next-Year EPS Estimate 57.64%
As of 2026-06-11, Supernus Pharmaceuticals Inc (SUPN) has a next-year EPS growth estimate of 57.64%.
On 2026-06-04, analyst consensus for SUPN's next-year EPS growth shifted from 58.98% to 57.64% — a negative change of 1.34 percentage points. The revised estimate has been sustained across 6 subsequent trading sessions. Current-year growth is projected at -23.13%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 57.64%
- EPS growth this year
- -23.13%
- EPS next quarter (est)
- $0.43
- Last price
- $45.55
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 57.64% | -23.13% | $0.43 | $45.55 |
| 2026-06-10 | 57.64% | -23.13% | $0.43 | $45.09 |
| 2026-06-09 | 57.64% | -23.13% | $0.43 | $45.66 |
| 2026-06-08 | 57.64% | -23.13% | $0.43 | $44.48 |
| 2026-06-07 | 57.64% | -23.13% | $0.43 | $44.75 |
| 2026-06-04 | 57.64% | -23.13% | $0.43 | $44.70 |
| 2026-06-03 | 58.98% | -23.44% | $0.44 | $44.03 |
| 2026-06-02 | 58.98% | -23.44% | $0.44 | $44.07 |
| 2026-06-01 | 58.98% | -23.44% | $0.44 | $44.76 |
| 2026-05-31 | 58.98% | -23.44% | $0.44 | $46.18 |
| 2026-05-28 | 58.98% | -23.44% | $0.44 | $46.85 |
| 2026-05-27 | 58.98% | -23.44% | $0.44 | $46.64 |
| 2026-05-26 | 58.98% | -23.44% | $0.44 | $47.77 |
| 2026-05-25 | 58.98% | -23.44% | $0.44 | $48.21 |
| 2026-05-24 | 58.98% | -23.44% | $0.44 | $48.21 |
| 2026-05-21 | 58.98% | -23.44% | $0.44 | $49.38 |
| 2026-05-20 | 58.98% | -23.44% | $0.44 | $48.69 |
| 2026-05-19 | 58.98% | -23.44% | $0.44 | $47.62 |
| 2026-05-18 | 58.98% | -23.44% | $0.44 | $48.33 |
| 2026-05-17 | 58.98% | -23.44% | $0.44 | $49.43 |
| 2026-05-14 | 58.98% | -23.44% | $0.44 | $51.20 |
| 2026-05-13 | 58.98% | -23.44% | $0.44 | $51.06 |
| 2026-05-12 | 58.98% | -23.44% | $0.44 | $50.53 |
| 2026-05-11 | 58.98% | -23.44% | $0.44 | $49.37 |
| 2026-05-10 | 58.98% | -23.44% | $0.44 | $51.53 |
| 2026-05-07 | 58.98% | -23.44% | $0.44 | $52.28 |
| 2026-05-06 | 58.98% | -23.44% | $0.44 | $51.45 |
| 2026-05-05 | 81.89% | -33.00% | $0.30 | $49.19 |
| 2026-05-04 | 81.89% | -33.00% | $0.30 | $48.63 |
| 2026-05-03 | 81.89% | -33.00% | $0.30 | $47.85 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Supernus Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Supernus Pharmaceuticals Inc (SUPN) has a next-year EPS growth estimate of 57.64%, based on analyst consensus.
When was the latest EPS estimate revision for SUPN?▾
The most recent revision occurred on 2026-06-04, when analysts adjusted the next-year EPS growth estimate from 58.98% to 57.64%.
What sector and industry does Supernus Pharmaceuticals Inc belong to?▾
Supernus Pharmaceuticals Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SUPN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Supernus Pharmaceuticals Inc (SUPN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports